MSC for Treatment of cGVHD After Allo-HSCT

NCT04692376 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

152

Enrollment

OTHER

Sponsor class

Conditions

Chronic Graft-versus-host Disease

Interventions

BIOLOGICAL: Mesenchymal stem cells
DRUG: Glucocorticoids
DRUG: cyclosporine

Sponsor

Nanfang Hospital, Southern Medical University

Collaborators

[object Object]
[object Object]
[object Object]